Author Affiliations1S. Fyodorov Eye Microsurgery Federal State Institution, Novosibirsk Branch, 630071, Novosibirsk, Kolkhidskaya str., 10
2S. Fyodorov Eye Microsurgery Federal State Institution, Novosibirsk Branch, 630096, Novosibirsk, Kolkhidskaya str., 10; Research Center of Clinical and Experimental Medicine of SB RAMS, 630117, Novosibirsk, Timakov str., 2
3S. Fyodorov Eye Microsurgery Federal State Institution, Novosibirsk Branch,630071, Novosibirsk, Kolkhidskaya str., 10
4S. Fyodorov Eye Microsurgery Federal State Institution, Novosibirsk Branch,630071, Novosibirsk, Kolkhidskaya str., 10
5S. Fyodorov Eye Microsurgery Federal State Institution, Novosibirsk Branch,630071, Novosibirsk, Kolkhidskaya str., 10
6Research Center of Clinical and Experimental Medicine of SB RAMS, 63011, Novosibirsk, Timakov str., 2
7Research Center of Clinical and Experimental Medicine of SB RAMS, 630117, Novosibirsk, Timakova str., 2
8Research Center of Clinical and Experimental Medicine of SB RAMS, 630117, Novosibirsk, Timakova str., 2
1. Ocular manifestations of diabetes / Ed. L.I. Balashevich. Saint-Petersburg, 2004. 382 p. (in Russian)
2. Libman E.S., Shahova E.V. Blindness and disability due to pathology of the vision in Russia // Vestnik oftalmologii. 2006. (1). 35–37. (in Russian)
3. Slepova O.S., Neroev V.V. Ilyukhin P.A., Sarygina O.I. Immunological control of in the surgical treatment of patients with proliferative diabetic retinopathy with preliminary introduction to the vitreous Lucentis // Rossiyskiy oftal'mologicheskiy zhurnal. 2012.1. 69–74. (in Russian)
4. Chernykh V.V., Lysikov A.G., Obukhova O.O. et al. Features of local immunoinflammatory process at nonproliferative diabetic retinopathy // Byulleten' Novosibirskogo gosudarstvennogo universiteta. 2011. 9. (1). 64–168. (in Russian)
5. Chernykh V.V., Varvarinsky E.V., Gorbenko O.M. et al. Activity of the local inflammatory and proliferative processes in the pathogenesis of diabetic retinopathy // Byulleten' Sibirskogo otdeleniya Rossiyskoy akademii meditsinskikh nauk. 2013. 33. (5). 60–63. (in Russian)
6. Bhavsar A.R. Diabetic retinopathy: the latest in current management // Retina. 2006. 26. (6). 71–79.
7. Citirik M., Kabatas E.U., Batman C. et al. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy // Ophthalmic Res. 2012. 47. (1). 7–12.
8. Goede V., Brogelli L., Ziche M., Augustin H.G. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1 // Int. J. Cancer. 1999. 82. (5). 765–770.
9. Kanellakis P., Ditiatkovski M., Kostolias G., Bobik A. A pro-fibrotic role for interleukin-4 in cardiac pressure overload // Cardiovasc. Res. 2012. 95. (1). 77–85.
10. Kang M.H., Kim M.K., Lee H.J. et al. Interleukin-17 in various ocular surface inflammatory diseases // J. Korean Med. Sci. 2011. 26. (7). 938–944.
11. Kollias A.N., Ulbig M.W. Diabetic retinopathy: Early diagnosis and effective treatment // Dtsch. Arztebl. Int. 2010. 107. (5). 75–83.
12. Kowluru R.A., Zhong Q., Kanwar M. Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal pericytes // Exp. Eye Res. 2010. 90. (5). 617–623.
13. Lim A., Stewart J., Chui T.Y. et al. Prevalence and risk factors of diabetic retinopathy in a multi-racial underserved population // Ophthalmic Epidemiol. 2008. 15. (6). 402–409.
14. Neurath M.F., Finotto S. IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer // Cytokine Growth Factor Rev. 2011. 22. (2). 83–89.
15. Matsuoka M., Ogata N., Minamino K., Matsumura M. Expression of pigment epithelium-derived factor and vascular endothelial growth factor in fibrovascular membranes from patients with proliferative diabetic retinopathy // Jpn. J. Ophthalmol. 2006. 50. (2). 116–120.
16. Mohan N., Monickaraj F., Balasubramanyam M. et al. Imbalanced levels of angiogenic and angiostatic factors in vitreous, plasma and postmortem retinal tissue of patients with proliferative diabetic retinopathy // J. Diabetes Complications. 2012. 26. (5). 435–441.
17. Murugeswari P., Shukla D., Rajendran A. et al. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales’ disease // Retina. 2008. 28. (6). 817–824.
18. Ogata N., Nishikawa M., Nishimura T. et al. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy // Am. J. Ophthalmol. 2002. 134. (3). 348–353.
19. Pennock S., Kazlauskas A. Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses // Mol. Cell Biol. 2012. 32. (10). 1955–1966.
20. Postlethwaite A.E., Holness M.A., Katai H., Raghow R. Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4 // J. Clin. Invest. 1992. 90. (4). 1479–1485.
21. Regan D.P., Aarnio M.C., Davis W.S. et al. Characterization of cytokines associated with Th17 cells in the eyes of horses with recurrent uveitis // Vet. Ophtalmol. 2012. 15. (3). 145–152.
22. Salcedo R., Ponce M.L., Young H.A. et al. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression // Blood. 2000. 96. (1). 34–40.
23. Sadaka A., Giuliari G.P. Proliferative vitreoretinopathy: current and emerging treatments // Clin. Ophthalmol. 2012. 6. 1325–1333.
24. Suzuki Y., Nakazawa M., Suzuki K., Yamazaki H., Miyagawa Y. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion // Jpn. J. Ophthalmol. 2011. 55. (3). 256–263.
25. Symeonidis C., Papakonstantinou E., Androudi S. et al. Interleukin-6 and the matrix metalloproteinase response in the vitreous during proliferative vitreoretinopathy // Cytokine. 2011. 54. (2). 212–217.
26. Wakabayashi Y., Usui Y., Okunuki Y. et al. Correlation of vascular endothelial growth factor with chemokines in the vitreous in diabetic retinopathy // Retina. 2010. 30. (2). 339–344.
27. Wakabayashi Y., Usui Y., Okunuki Y. et al. Increases of vitreous monocyte chemotactic protein 1 and interleukin 8 levels in patients with concurrent hypertension and diabetic retinopathy // Retina. 2011. 31. (9). 1951–1957.
28. Wakabayashi Y., Usui Y., Okunuki Y. et al. Intraocular VEGF level as a risk factor for postoperative complications after vitrectomy for proliferative diabetic retinopathy // Invest. Ophthalmol. Vis. Sci. 2012. 53. (10). 6403–6410.
